Literature DB >> 7725065

Interleukin-10 directly inhibits the interleukin-6 production in T-cells.

L Hempel1, D Körholz, H Bönig, M Schneider, A Klein-Vehne, J Packeisen, C Mauz-Körholz, S Burdach.   

Abstract

IL-6 is a potent regulator of T-cell activation, proliferation and differentiation. Since IL-10 inhibits cytokine production by T cells, the effect of IL-10 on IL-6 production by T cells was investigated. IL-6 production by purified monocytes or T cells was detected from cell-free culture supernatants by ELISA after stimulation of the cells with LPS or an anti-CD3 monoclonal antibody for 3 days. Although the main source of IL-6 are LPS activated monocytes (29.6 +/- 10 ng/ml), T cells secreted sufficiently high levels of IL-6 (790 +/- 200 pg/ml) to stimulate the high affinity IL-6 receptor. IL-10 decreased anti-CD3 induced IL-6 mRNA expression by up to 80%. In addition, IL-10 significantly inhibited IL-6 release from T-cells. Highly purified, anti-CD3 activated T-cells secreted 600 +/- 150 pg/ml IL-6 compared to 21 +/- 2 pg/ml IL-6 following addition of IL-10 (10 ng/ml; P < 0.001). FACS analysis revealed a monocyte contamination of the T-cell preparations of less than 0.5%. In addition, no IL-1 production was detectable. Thus, in our experiments the effect of IL-10 on IL-6 production was independent of the presence of monocytes. Finally, inhibition of IL-6 production was not reversed by IL-2 (100 U/ml). In conclusion, IL-10 suppressed the synthesis of IL-6 by T-cells via a monocyte- and IL-2-independent mechanism. These results may help to understand the complex regulation of T-cell mediated cytokine production by IL-10.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7725065     DOI: 10.1111/j.1365-3083.1995.tb03593.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  2 in total

1.  Interaction between cytokine gene polymorphisms and the effect of physical exercise on clinical and inflammatory parameters in older women: study protocol for a randomized controlled trial.

Authors:  Daniele S Pereira; Bárbara Z Queiroz; Elvis C C Mateo; Alexandra M Assumpção; Diogo C Felício; Aline S Miranda; Daniela M C Anjos; Fabianna Jesus-Moraleida; Rosângela C Dias; Danielle A G Pereira; Antônio L Teixeira; Leani S M Pereira
Journal:  Trials       Date:  2012-08-08       Impact factor: 2.279

2.  Polymeric nanoparticles containing rapamycin and autoantigen induce antigen-specific immunological tolerance for preventing vitiligo in mice.

Authors:  Xia Zhang; Daji Liu; Minghong He; Mao Lin; Caixia Tu; Baoxiang Zhang
Journal:  Hum Vaccin Immunother       Date:  2021-02-22       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.